Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)

Background: Assessment of actionable EGFR mutations is mandatory for treatment-naïve advanced or metastatic non-squamous lung carcinoma (NSLC), but the results need to be obtained in less than 10 working days. For rapid EGFR testing, an EGFR-specific polymerase chain reaction (PCR) assay is an alter...

Descripción completa

Detalles Bibliográficos
Autores principales: Lassalle, Sandra, Hofman, Véronique, Heeke, Simon, Benzaquen, Jonathan, Long, Elodie, Poudenx, Michel, Lantéri, Elisabeth, Boutros, Jacques, Tanga, Virginie, Zahaf, Katia, Lalvée, Salomé, Lespinet, Virginie, Bordone, Olivier, Félix, Jean-Marc, Bonnetaud, Christelle, Marquette, Charles, Ilie, Marius, Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225982/
https://www.ncbi.nlm.nih.gov/pubmed/32294880
http://dx.doi.org/10.3390/cancers12040955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225982/
https://www.ncbi.nlm.nih.gov/pubmed/32294880
http://dx.doi.org/10.3390/cancers12040955

Ejemplares similares